温州医科大学学报
溫州醫科大學學報
온주의과대학학보
Journal of Wenzhou Medical University
2015年
2期
131-134
,共4页
杨沛%周颖%张学政%蒋柳明%张东琦
楊沛%週穎%張學政%蔣柳明%張東琦
양패%주영%장학정%장류명%장동기
悬雍垂腭咽成形术%镇静%右美托咪定%咪达唑仑%阻塞性睡眠呼吸暂停低通气综合征
懸雍垂腭嚥成形術%鎮靜%右美託咪定%咪達唑崙%阻塞性睡眠呼吸暫停低通氣綜閤徵
현옹수악인성형술%진정%우미탁미정%미체서륜%조새성수면호흡잠정저통기종합정
uvulopalatopharyngoplasty%sedation%dexmedetomidine%midazolam%obstructive sleep apnea hypopnea syndrome
目的:比较右美托咪定与咪达唑仑用于阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者行悬雍垂腭咽成形术(UPPP)术后的镇静效果。方法:选择择期行UPPP术的OSAHS患者64例,随机分为右美托咪定组(D组,n=32)和咪达唑仑组(M组,n=32)。术毕入重症监护室行机械通气,2组分别输注右美托咪定和咪达唑仑,使Ramsay评分维持于3~4分,复合舒芬太尼镇痛。如出现高血压或心动过速,予额外药物处理。并于入室2 h(T1)、10 h(T2)、20 h(T3)、拔管前即刻(T4)等时点监测患者应激激素水平。患者入室20 h停镇静药,拔管后待Aldrete评分达10分返回病房。结果:63例达预期镇静,D组24例不需额外药物调整血压或心率,M组8例,差异有统计学意义(P<0.05)。各时点平均应激激素水平D组均低于M组,且各时点血压和心率均低于M组(P<0.05)。D组停药至出重症监护室时间更短,且患者对镇静满意度评分更高(P<0.05)。结论:对于行UPPP术的OSAHS患者,术后于重症监护室机械通气时使用右美托咪定镇静比咪达唑仑更具有优势。
目的:比較右美託咪定與咪達唑崙用于阻塞性睡眠呼吸暫停低通氣綜閤徵(OSAHS)患者行懸雍垂腭嚥成形術(UPPP)術後的鎮靜效果。方法:選擇擇期行UPPP術的OSAHS患者64例,隨機分為右美託咪定組(D組,n=32)和咪達唑崙組(M組,n=32)。術畢入重癥鑑護室行機械通氣,2組分彆輸註右美託咪定和咪達唑崙,使Ramsay評分維持于3~4分,複閤舒芬太尼鎮痛。如齣現高血壓或心動過速,予額外藥物處理。併于入室2 h(T1)、10 h(T2)、20 h(T3)、拔管前即刻(T4)等時點鑑測患者應激激素水平。患者入室20 h停鎮靜藥,拔管後待Aldrete評分達10分返迴病房。結果:63例達預期鎮靜,D組24例不需額外藥物調整血壓或心率,M組8例,差異有統計學意義(P<0.05)。各時點平均應激激素水平D組均低于M組,且各時點血壓和心率均低于M組(P<0.05)。D組停藥至齣重癥鑑護室時間更短,且患者對鎮靜滿意度評分更高(P<0.05)。結論:對于行UPPP術的OSAHS患者,術後于重癥鑑護室機械通氣時使用右美託咪定鎮靜比咪達唑崙更具有優勢。
목적:비교우미탁미정여미체서륜용우조새성수면호흡잠정저통기종합정(OSAHS)환자행현옹수악인성형술(UPPP)술후적진정효과。방법:선택택기행UPPP술적OSAHS환자64례,수궤분위우미탁미정조(D조,n=32)화미체서륜조(M조,n=32)。술필입중증감호실행궤계통기,2조분별수주우미탁미정화미체서륜,사Ramsay평분유지우3~4분,복합서분태니진통。여출현고혈압혹심동과속,여액외약물처리。병우입실2 h(T1)、10 h(T2)、20 h(T3)、발관전즉각(T4)등시점감측환자응격격소수평。환자입실20 h정진정약,발관후대Aldrete평분체10분반회병방。결과:63례체예기진정,D조24례불수액외약물조정혈압혹심솔,M조8례,차이유통계학의의(P<0.05)。각시점평균응격격소수평D조균저우M조,차각시점혈압화심솔균저우M조(P<0.05)。D조정약지출중증감호실시간경단,차환자대진정만의도평분경고(P<0.05)。결론:대우행UPPP술적OSAHS환자,술후우중증감호실궤계통기시사용우미탁미정진정비미체서륜경구유우세。
Objective:To compare the effect of sedation between dexmedetomidine and midazolam for se-vere obstructive sleep apnea hypopnea syndrome (OSAHS) after uvulopalatopharyngoplasty (UPPP). Methods:Sixty-four ASA I~II patients of severe OSAHS scheduled for UPPP were randomly allocated into group D (dex-medetomidine, n=32) and group M (midazolam, n=32). The patients of the two groups were sedated with dexme-detomidine or midazolam respectively in the ICU after surgery and Ramsay scores of 3-4 were maintained. Suf-entanil were added for analgesia. The supposed hypertension or tachycardia were treated with extra medication. The administration of sedative was stopped after 20 hours stay in ICU and the patients were sent back to ward when the Aldrete score reached 10. Results:The anticipated depth of sedation were acquired in 63 patients and there was a signiifcant difference (P<0.05) demonstrated by 24 patients in group D while 8 patients in group M received no extra medication for hypertension or tachycardia. The level of stress hormone, the mean arterial pres-sure and heart rate were signiifcantly lower in group D than group M at 2 h (T1), 10 h (T2), 20 h (T3) after entering ICU and before extubation (T4) respectively. The time intervals between medication suspend and departure from ICU were signiifcantly shorter while the degree of satisfaction for the process of sedation were higher in group D than that in group M. Conclusion:Dexmedetomidine has better features of sedation than midazolam for the pa-tients of severe OSAHS with mechanical ventilation after UPPP in ICU.